Tools for Improving Colorectal Cancer Screening Rates: Multimedia Versus Print
Public ClinicalTrials.gov record NCT01072851. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tools for Improving Colorectal Cancer Screening Rates: Multimedia vs Print
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to compare the effectiveness of multimedia and print tools designed to provide patients at safety-net clinics with comprehensible information about colorectal cancer screening and motivate them to complete screening.The print and multimedia interventions were constructed with parallel content to allow valid comparison of format-related effects on knowledge and screening rates.These easy to use tools will provide under served patients at community health centers with clear and consistent messages about colorectal Cancer(CRC) and CRC screening, delivered immediately before the patients see a doctor. Specific Aims 1. To determine if multimedia and print interventions that provide patients with information and motivational messages about CRC screening increase screening rates above usual care. 2. Determine whether showing patients a multimedia program achieves higher CRC screening rates than does a print booklet with equivalent messages. 1. Examine if the effects of these multimedia and print interventions on CRC screening rates differ with literacy level. 2. Examine if the effects of these multimedia and print interventions on CRC screening differ with race/ethnicity 3. Examine if these multimedia and print interventions have differential effects on knowledge relevant to CRC screening.
Study identification
- NCT ID
- NCT01072851
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 920 participants
Conditions and interventions
Conditions
Interventions
- Multimedia Education Behavioral
- Print Media Behavioral
- Usual and customary waiting room process Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 50 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2008
- Primary completion
- Jun 30, 2012
- Completion
- Aug 31, 2012
- Last update posted
- Sep 6, 2012
2008 – 2012
United States locations
- U.S. sites
- 3
- U.S. states
- 1
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Midlakes Medical Building | Highland Park | Illinois | 60085 | — |
| North Chicago Health Center | North Chicago | Illinois | 60064 | — |
| Belvidere Medical Building | Waukegan | Illinois | 60085 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01072851, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 6, 2012 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01072851 live on ClinicalTrials.gov.